Chief Executive Officer
Mr. Liu Dong is a veteran biomedical entrepreneur, with proven track records in pharmaceutical enterprise management, operations, and business development.
• He has over 20 years of leadership experience in multinational corporations, where he served as senior pharmaceutical management leader and business development (BD) expert.
• Executive Education, Harvard Business School; eMBA, China Europe International Business School (CEIBS).
• Former General Manager of the Health Business Unit at Merck Sharp & Dohme (MSD) China; General Manager of Oncology Business at Fresenius (China); Business Unit Head for Specialty Care at Ipsen (China).
• He had successfully led teams of nearly 1,000 professionals across multiple therapeutic areas including oncology, men's health, women's health, and cardiovascular diseases, building and scaling multiple blockbuster products exceeding RMB 1 billion in revenue.
Posts recommend
-
Time:2026-07-10
-
Time:2026-07-10
-
Time:2026-07-10



